Results, Reports and Publications
Latest Results
Clariant delivers solid Q4 underlying EBITDA margin; proposes stable shareholder distribution per share; expects growth and improving profitability in 2024
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
- Q4 2023: Sales decreased by 10 % organically in local currency1 to CHF 1.062 billion against a strong comparable in Q4 2022; sequential sales increase of 4 % in local currency driven by volume growth
- Q4 2023: EBITDA margin of 10.0 % impacted by provisions related to sunliquid® decision and restructuring; underlying EBITDA margin before exceptional items of 14.9 %
- FY 2023: Sales decreased by 7 % organically in local currency to CHF 4.377 billion due to lower volumes despite maintaining stable pricing; EBITDA margin of 13.9 %, and 14.6 % before exceptional items
- FY 2023: Resilient free cash flow of CHF 216 million, resulting in a 36 % free cash flow conversion rate
- FY 2023: Distribution of CHF 0.42 per share proposed to AGM on 9 April 2024
- Outlook 2024: In a continued challenging macroeconomic environment, Clariant targets low single-digit local currency growth and an improvement in reported EBITDA margin to around 15 % (around 16 % excluding sunliquid® operational and exceptional impacts)
- Medium-term targets: Clariant remains firmly committed to its targets, with 2025 EBITDA margin now expected at 17 % – 18 % showing significant progress toward the 19 % – 21 % target
"In the fourth quarter of 2023, we saw sequential revenue improvement while end markets stabilized. Robust performance in the quarter was nevertheless below the strong base of the prior year, when Catalysts delivered record sales. With the imminent completion of the acquisition of Lucas Meyer Cosmetics and our decision to cease operations at the sunliquid® plant, we have positioned the company for higher growth and improved profitability, taking another step forward in our purpose-led growth strategy,” said Conrad Keijzer, Chief Executive Officer of Clariant.
1All references to local currency growth, pricing, volumes, and scope exclude the impact from hyperinflation countries Argentina and Türkiye. All references to currency include a net impact from hyperinflation countries Argentina and Türkiye.
Upcoming Results
On 30 April 2024, Clariant will present its First Quarter Figures 2024.
The results will be published at 7.00 AM CEST and a conference call and webcast for analysts and investors will start at 15.00 CEST.
Conference call participants are kindly requested to register here.
Results Center
Please use the Results Center to find Clariant’s financial results and associated documents as published in the last five years
Q1 Q2 Q3 Q4 Date 5 May 2023 28 July 2023 30 October 2023 29 February 2024 Quiet Period as of 17 April as of 10 July as of 10 October as of 15 January Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Link Audio recording MP3 MP3 MP3 MP3 Transcript EN EN EN EN Financial Review / HY Report EN EN — XLS Annual Report EN
Q1 Q2 Q3 Q4 Date 15 June 2022 28 July 2022 27 October 2022 2 March 2023 Quiet Period as of 11 July as of 10 October as of 17 February Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript
EN Financial Review / HY Report EN EN Annual Report EN
Q1 Q2 Q3 Q4 Date 29 April 2021 29 July 2021 28 October 2021 19 May 2022 Quiet Period as of 19 April as of 12 July as of 18 October Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript
Financial Review / HY Report EN EN Annual Report EN
Conferences and Roadshows
Clariant's Management and Investor Relations Team regularly participates in Conferences and Roadshows. Below you can find an overview of the presentations provided at such events in the last two years.
For an overview of upcoming events, please refer to the Financial Calendar.
